COMPASS Pathways Plc - American Price Today
COMPASS Pathways Plc - American
CMPS
Healthcare
$625.57M
💰
Market Cap
0
💸
Price to Earnings
$-2.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
4 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
CMPS Price Forecast Target
9.7 👉 120.0 +1132%
CMPS EPS Forecast
-2.3 👉 -2.2 +-4%
Financials
Profit Margin
0 %
Revenue Growth
0 %
Dividend
$ 0
Held Percent
30.3% - Insiders
36.6% - Institutions
33.1% - Public
Major Fund Holders
-
💰 TCG Crossover Management, LLC $37.6M
-
💰 ARK Investment Management, LLC $25.5M
-
💰 Paradigm Biocapital Advisors LP $22.1M
-
💰 Vivo Capital, LLC $15.7M
-
💰 Citadel Advisors Llc $15.2M
Stock Ideas
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…📮FAQ
Some Frequently Asked Questions.
The COMPASS Pathways Plc - American industry is Medical Care Facilities
The COMPASS Pathways Plc - American sector is Healthcare
The COMPASS Pathways Plc - American forecasted predicted Price to Earnings PE ratio is -4.4
The COMPASS Pathways Plc - American Price to Earnings PE ratio is 0
The Market Capitalization of COMPASS Pathways Plc - American is $625.57M
There are total of 39324492 float shares with 36.6% held by Institutions and 30.3% held by insiders
The MCOMPASS Pathways Plc - American forecasted Earnings per Share EPS is $-2.2
The COMPASS Pathways Plc - American Earnings per Share EPS is -2.3
The COMPASS Pathways Plc - American company has $0 gross profits with 0 profit margins
The COMPASS Pathways Plc - American Earnings Growth is 0% with 0% quarterly earnings growth
The COMPASS Pathways Plc - American Revenue is $0 with 0 revenue growth
The price target for COMPASS Pathways Plc - American stock is $120.0 for the high target and $16.0 for the low target
The consensus analyst recommendations for COMPASS Pathways Plc - American is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for COMPASS Pathways Plc - American is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of COMPASS Pathways Plc - American is 2.5
The dividend of COMPASS Pathways Plc - American is $0
The dividend yield of COMPASS Pathways Plc - American is 0%
The biggest institutional and mutual fund holders of COMPASS Pathways Plc - American stock are
- TCG Crossover Management, LLC
- ARK Investment Management, LLC
- Paradigm Biocapital Advisors LP
- Vivo Capital, LLC
The COMPASS Pathways Plc - American ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0